{"title":"Heterogeneity in racial and ethnic disparities in COVID-19 severity among pediatric inpatients in a national healthcare database.","authors":"David Watson, Alicen B Spaulding, Laura Norton","doi":"10.1093/jpids/piaf092","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The COVID-19 pandemic magnified longstanding racial and ethnic disparities in pediatric health, but it is unclear which populations experienced the largest disparities. Our objective was to determine if disparities in COVID-19 severity differed with respect to patient factors analyzed as effect modifiers.</p><p><strong>Methods: </strong>Using data from the Premier Healthcare Database, this retrospective cohort study included encounters among inpatients <19 years old from April 2020 through September 2022 in the US with COVID-19 diagnosis. Outcomes of COVID-19 severity were intensive care unit (ICU) admission and ventilator use. Comparisons between Black and White patients and Hispanic and White patients were adjusted for confounders using propensity score weights, reported as risk differences (RDs) in percentage points, and tested for heterogeneity (interaction-p) across subgroups of effect modifiers such as complex chronic conditions (CCCs) and insurance status.</p><p><strong>Results: </strong>Of 8947 pediatric inpatients with primary COVID-19 diagnosis, 3858 were White, 2153 were Black, and 2936 were Hispanic. Among children with a CCC, 14.3% of Black inpatients required a ventilator compared to 9.8% of White inpatients; among children without a CCC, 3.2% of both Black and White inpatients required a ventilator (RDs 4.5 vs. 0.0; interaction-p=.013). Comparisons of Hispanic and White inpatients showed a similar trend in ventilator use, with larger disparities among inpatients with CCCs and no difference among those without CCCs (RDs 2.7 vs. -0.7; interaction-p=.031). Among children with government insurance, 25.9% of Black inpatients were admitted to the ICU compared to 20.8% of White inpatients; among children with private insurance, Black and White inpatients had comparable ICU admission rates of 20.0% and 21.4%, respectively (RDs 5.1 vs. -1.4; interaction-p=.025).</p><p><strong>Conclusions: </strong>Among hospitalized children, racial and ethnic disparities in COVID-19 severity were largest for those with CCCs or government insurance. These results can help identify target populations for interventions to reduce inequity.</p>","PeriodicalId":17374,"journal":{"name":"Journal of the Pediatric Infectious Diseases Society","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Pediatric Infectious Diseases Society","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jpids/piaf092","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The COVID-19 pandemic magnified longstanding racial and ethnic disparities in pediatric health, but it is unclear which populations experienced the largest disparities. Our objective was to determine if disparities in COVID-19 severity differed with respect to patient factors analyzed as effect modifiers.
Methods: Using data from the Premier Healthcare Database, this retrospective cohort study included encounters among inpatients <19 years old from April 2020 through September 2022 in the US with COVID-19 diagnosis. Outcomes of COVID-19 severity were intensive care unit (ICU) admission and ventilator use. Comparisons between Black and White patients and Hispanic and White patients were adjusted for confounders using propensity score weights, reported as risk differences (RDs) in percentage points, and tested for heterogeneity (interaction-p) across subgroups of effect modifiers such as complex chronic conditions (CCCs) and insurance status.
Results: Of 8947 pediatric inpatients with primary COVID-19 diagnosis, 3858 were White, 2153 were Black, and 2936 were Hispanic. Among children with a CCC, 14.3% of Black inpatients required a ventilator compared to 9.8% of White inpatients; among children without a CCC, 3.2% of both Black and White inpatients required a ventilator (RDs 4.5 vs. 0.0; interaction-p=.013). Comparisons of Hispanic and White inpatients showed a similar trend in ventilator use, with larger disparities among inpatients with CCCs and no difference among those without CCCs (RDs 2.7 vs. -0.7; interaction-p=.031). Among children with government insurance, 25.9% of Black inpatients were admitted to the ICU compared to 20.8% of White inpatients; among children with private insurance, Black and White inpatients had comparable ICU admission rates of 20.0% and 21.4%, respectively (RDs 5.1 vs. -1.4; interaction-p=.025).
Conclusions: Among hospitalized children, racial and ethnic disparities in COVID-19 severity were largest for those with CCCs or government insurance. These results can help identify target populations for interventions to reduce inequity.
背景:2019冠状病毒病大流行放大了儿科健康方面长期存在的种族和民族差异,但尚不清楚哪些人群的差异最大。我们的目的是确定COVID-19严重程度的差异是否与作为效果调节剂分析的患者因素有关。方法:采用来自Premier Healthcare数据库的数据,对住院患者进行回顾性队列研究。结果:8947例初诊COVID-19的儿科住院患者中,3858例为白人,2153例为黑人,2936例为西班牙裔。在患有CCC的儿童中,14.3%的黑人住院患者需要呼吸机,而白人住院患者的这一比例为9.8%;在没有CCC的儿童中,3.2%的黑人和白人住院患者需要呼吸机(RDs为4.5 vs. 0.0;交互作用p= 0.013)。西班牙裔和白人住院患者在呼吸机使用方面的比较显示出类似的趋势,有CCCs的住院患者差异较大,无CCCs的住院患者无差异(RDs为2.7 vs. -0.7;相互作用p= 0.031)。在有政府保险的儿童中,25.9%的黑人住院患者进入ICU,而白人住院患者的这一比例为20.8%;在拥有私人保险的儿童中,黑人和白人住院患者的ICU住院率分别为20.0%和21.4% (RDs为5.1 vs. -1.4;相互作用p= 0.025)。结论:在住院儿童中,患有CCCs或政府保险的儿童在COVID-19严重程度上的种族和民族差异最大。这些结果有助于确定干预措施的目标人群,以减少不平等现象。
期刊介绍:
The Journal of the Pediatric Infectious Diseases Society (JPIDS), the official journal of the Pediatric Infectious Diseases Society, is dedicated to perinatal, childhood, and adolescent infectious diseases.
The journal is a high-quality source of original research articles, clinical trial reports, guidelines, and topical reviews, with particular attention to the interests and needs of the global pediatric infectious diseases communities.